Serge A. Jabbour
Expertise in
31
conditions

Dr. Serge A. Jabbour

Endocrinology
211 South 9th Street, Suite 600, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
31
conditions
211 South 9th Street, Suite 600, 
Philadelphia, PA 

Overview

Serge Jabbour is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Jabbour is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypothyroidism, Papillary Thyroid Cancer, and Pancreaticoduodenectomy.

Dr. Jabbour is board certified in Internal Medicine and Endocrinology. He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 5 clinical trials. Dr. Jabbour is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in PA

Board Certifications

Internal Medicine
Endocrinology

Fellowships

Thomas Jefferson University Hospitals

Hospital Affiliations

Thomas Jefferson University Hospital
Hospital Of Univ Of Pennsylvania
Pennsylvania Hospital
Bryn Mawr Hospital
Thomas Jefferson University Hospital
Main Line Hospital Lankenau

Languages Spoken

English
Arabic
French

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 25 Less Insurance Carriers -

Locations

Jefferson Endocrinology & Diabetes Associates
211 South 9th Street, Suite 600, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Jabbour has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Acromegaly
Empty Sella Syndrome
Addison's Disease

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET® System for Glycemic Improvement in Patients With Inadequately Controlled Type 2 Diabetes and Obesity
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET® System for Glycemic Improvement in Patients With Inadequately Controlled Type 2 Diabetes and Obesity
Enrollment Status: Recruiting
Publish Date: July 18, 2024
Intervention Type: Device, Other
Study Phase: Not Applicable
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

48 Total Publications

Role of the trigeminal system in pancreatic innervation: new concept and challenge - a narrative review.
Role of the trigeminal system in pancreatic innervation: new concept and challenge - a narrative review.
Journal: Endocrine research
Published: February 17, 2026
Similar Doctors
Expertise in
24
conditions
Dr. Michael A. Levine
Endocrinology
Expertise in
24
conditions
Dr. Michael A. Levine
Endocrinology
Referral required
Before you request

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (2.1 miles away)
215-590-3174
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Levine is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Levine is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Milk-Alkali Syndrome, Hypercalcemia, Hormone Replacement Therapy (HRT), and Parathyroidectomy. Dr. Levine is currently accepting new patients.

Expertise in
39
conditions
Dr. Peter J. Snyder
Endocrinology
Expertise in
39
conditions
Dr. Peter J. Snyder
Endocrinology
Referral required
Before you request

Penn Pituitary Center

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (2.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Snyder is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Snyder is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, Cushing's disease, and Hormone Replacement Therapy (HRT). Dr. Snyder is board certified in Endocrinology, Diabetes, & Metabolism, 1972 and Internal Medicine, 1972. Dr. Snyder is currently accepting new patients.

Expertise in
9
conditions
Dr. Susan J. Mandel
Endocrinology
Expertise in
9
conditions
Dr. Susan J. Mandel
Endocrinology
Referral required

Penn Endocrinology Perelman

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
 (2.0 miles away)
215-662-2300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Susan Mandel is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Mandel is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Follicular Thyroid Cancer, and Papillary Thyroid Cancer. Dr. Mandel is board certified in Endocrinology, Diabetes, & Metabolism, 1991 and Internal Medicine, 1989.

Frequently Asked Questions about Dr. Serge A. Jabbour

Is Dr. Serge A. Jabbour a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Serge A. Jabbour is classified as an Elite expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Serge A. Jabbour specialize in?

While Dr. Serge A. Jabbour is a Endocrinology, they have specific expertise in Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hypothyroidism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Serge A. Jabbour participate in research or clinical trials?

Yes. Dr. Serge A. Jabbour has published 48 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Dr. Serge A. Jabbour's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Serge A. Jabbour accept my insurance?

Dr. Serge A. Jabbour accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jabbour's expertise for a condition
ConditionClose
View All 25 Advanced Conditions
View All 66 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile